“Diabetes Breakthrough” The Unique combination for Diabetes Management

May 8, 2022

 
The ACME Laboratories Ltd. has arranged “Diabetes Breakthrough”, a Scientific Discussion session on Empagliflozin and Linagliptin, Powered by Emlino.

Emlino Tablets are the first in its class combination for the 1st time in Bangladesh that is a unique combination for diabetes management as well as to lower the risk of multiple end organ damages.

#EMLINO #ACME

#1st_time_in_Bangladesh

#DiabetesBreakthrough